Vanguard Personalized Indexing Management
TNXP icon

Vanguard Personalized Indexing Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-152
Closed -$2.26K – 1870
2024
Q3 		$2.26K Buy
+152
New +$6.12K ﹤0.01% 1775

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Vanguard Personalized Indexing Management's TNXP Position: Q4 2024 in Review

Vanguard Personalized Indexing Management sold out of Tonix Pharmaceuticals (TNXP) in Q4 2024, closing a stake of 152 shares — an estimated $2.26K sold.

Vanguard Personalized Indexing Management first reported a position in TNXP in Q3 2024 and held it in 1 quarter. The position peaked at $2.26K in Q3 2024. 32 funds tracked by Wall St. Rank hold TNXP as of Q4 2024.

  • Vanguard Personalized Indexing Management reported no remaining Tonix Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 152 Tonix Pharmaceuticals shares in Q4 2024, an estimated $2.26K.
  • Vanguard Personalized Indexing Management first reported a position in Tonix Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Tonix Pharmaceuticals position peaked at $2.26K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q4 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2024, filed 10 Feb 2025.